Blockade of CXCR2 signalling: A potential therapeutic target for preventing neutrophil-mediated inflammatory diseases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blockade of CXCR2 signalling: A potential therapeutic target for preventing neutrophil-mediated inflammatory diseases
Authors
Keywords
-
Journal
EXPERIMENTAL BIOLOGY AND MEDICINE
Volume 239, Issue 5, Pages 509-518
Publisher
SAGE Publications
Online
2014-03-14
DOI
10.1177/1535370213520110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi
- (2013) M. Ghasemzadeh et al. BLOOD
- Chemokine CXCL1 Dimer Is a Potent Agonist for the CXCR2 Receptor
- (2013) Aishwarya Ravindran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
- (2013) Laura Raccosta et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Chemokine Self-Presentation Mechanism Involving Formation of Endothelial Surface Microstructures
- (2013) C. Whittall et al. JOURNAL OF IMMUNOLOGY
- Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis
- (2013) B. Sharma et al. MOLECULAR CANCER THERAPEUTICS
- Chemokine contribution to neuropathic pain: Respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons
- (2013) Zhi-Jun Zhang et al. PAIN
- Getting Leukocytes to the Site of Inflammation
- (2013) W. A. Muller VETERINARY PATHOLOGY
- Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking
- (2012) Maria-Jesus Sanz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Chemokine receptor CXCR2: Physiology regulator and neuroinflammation controller?
- (2012) Mike Veenstra et al. JOURNAL OF NEUROIMMUNOLOGY
- CXCR2 in Acute Lung Injury
- (2012) F. M. Konrad et al. MEDIATORS OF INFLAMMATION
- The chemokine receptor CXCR2 and coronavirus-induced neurologic disease
- (2012) Jason G. Weinger et al. VIROLOGY
- Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases
- (2012) Madharasi VA Pichai WORLD JOURNAL OF GASTROENTEROLOGY
- CXCR2: From Bench to Bedside
- (2012) Anika Stadtmann et al. Frontiers in Immunology
- SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans
- (2011) Aili L. Lazaar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor
- (2011) R Bertini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor
- (2011) R. Virtala et al. CLINICAL AND EXPERIMENTAL ALLERGY
- CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1
- (2011) Saskia Braber et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth
- (2011) Simon Tazzyman et al. INTERNATIONAL JOURNAL OF CANCER
- A Chemokine Receptor CXCR2 Macromolecular Complex Regulates Neutrophil Functions in Inflammatory Diseases
- (2011) Yanning Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A common intracellular allosteric binding site for antagonists of the CXCR2 receptor
- (2010) K Salchow et al. BRITISH JOURNAL OF PHARMACOLOGY
- CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury
- (2010) Callisia Clarke et al. HEPATOLOGY
- Importance of CXC Chemokine Receptor 2 in Alveolar Neutrophil and Exudate Macrophage Recruitment in Response to Pneumococcal Lung Infection
- (2010) W. Herbold et al. INFECTION AND IMMUNITY
- Inhibition of CXCR1 and CXCR2 chemokine receptors attenuates acute inflammation, preserves gray matter and diminishes autonomic dysreflexia after spinal cord injury
- (2010) D R Marsh et al. SPINAL CORD
- Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis
- (2009) Soo-Hong Min et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor
- (2009) ME Bradley et al. BRITISH JOURNAL OF PHARMACOLOGY
- CXC Receptor-1 Silencing Inhibits Androgen-Independent Prostate Cancer
- (2009) N. Shamaladevi et al. CANCER RESEARCH
- SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects
- (2009) O. Holz et al. EUROPEAN RESPIRATORY JOURNAL
- Drug-Loaded Nanoparticles Targeted to the Colon With Polysaccharide Hydrogel Reduce Colitis in a Mouse Model
- (2009) Hamed Laroui et al. GASTROENTEROLOGY
- The functional significance behind expressing two IL-8 receptor types on PMN
- (2009) RoseMarie Stillie et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Therapeutic Effect of Blocking CXCR2 on Neutrophil Recruitment and Dextran Sodium Sulfate-Induced Colitis
- (2009) S. M. Farooq et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases
- (2009) W. Ulbrich et al. Journal of the Royal Society Interface
- Chitosan based nanocarriers for indomethacin ocular delivery
- (2008) Alia A. Badawi et al. ARCHIVES OF PHARMACAL RESEARCH
- CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2–DOP receptor heterodimer
- (2008) Geraldine Parenty et al. BIOCHEMICAL JOURNAL
- Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor
- (2008) Michael P. Winters et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice
- (2008) T M Cunha et al. BRITISH JOURNAL OF PHARMACOLOGY
- Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice
- (2008) A Zarbock et al. BRITISH JOURNAL OF PHARMACOLOGY
- The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice
- (2008) Allisson Freire Bento et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection
- (2008) M. Svensson et al. KIDNEY INTERNATIONAL
- CXCR2 antagonists for the treatment of pulmonary disease
- (2008) R.W. Chapman et al. PHARMACOLOGY & THERAPEUTICS
- Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats
- (2007) M M Barsante et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now